USD 5.76 billion
Transcatheter Embolization and Occlusion Devices Market Size, Share, Growth Analysis, By Type(Coil [Pushable Coils, Detachable Coils], Non-Coil [Flow Diverting Devices, Embolization Particles), By Application(Peripheral Vascular Disease [Arterial Blockage, Venous Blood clot, Others], Oncology [Liver Cancer), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35A2295 |
Region:
Global |
Published Date: October, 2024
Pages:
157
|Tables:
66
|Figures:
75
Transcatheter Embolization and Occlusion Devices Market Insights
Transcatheter Embolization and Occlusion Devices Market size was valued at USD 4.82 Billion in 2023 and is poised to grow from USD 5.17 Billion in 2024 to USD 9.02 Billion by 2032, growing at a CAGR of 7.20% during the forecast period (2025-2032).
Healthcare spending worldwide supports the development of highly advanced medical technologies, including implantable catheter devices and occlusion devices. The aging population with its higher susceptibility to certain conditions further drives market growth. Good reimbursement policies and insurance coverage encourage health care providers to use and service these devices. While these factors contribute to market growth, it is important to consider factors such as regulations and competition that influence the transcatheter embolization and occlusion devices industry.
The transcatheter embolization and occlusion devices market is emerging with opportunities for growth and development. Enhancing the indications for these devices offers significant opportunities to treat a wide range of conditions. Growing markets in regions such as Asia-Pacific and Africa give manufacturers untapped potential to establish their presence. Technological advances such as advanced device design, advanced imaging guidance, and integrated medical activity provide innovative approaches. Collaboration and partnerships among health professionals, manufacturers, and research institutes stimulates research and development efforts, and expands the market. Educating patients and healthcare professionals about the benefits of minimally invasive treatments to drive demand. By capitalizing on these opportunities through innovation that combines artificial intelligence and data analytics with machine capabilities for precision planning, real-time guidance, and personalized medicine management.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Embolization Coils
Fastest Growth
Embolization Coils
Growth Rate
9.89% CAGR
Global Transcatheter Embolization and Occlusion Devices By Country ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Transcatheter Embolization and Occlusion Devices Market Segmental Analysis
Global Transcatheter Embolization and Occlusion Devices Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Coil, and Non-Coil. Based on Application, the market is segmented into Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Type
The coil segment presently dominates the transcatheter embolization and occlusion devices market because of its sizable adoption in neurovascular tactics and its demonstrated efficacy in treating situations such as aneurysms and arteriovenous malformations (AVMs). Coils are preferred for their precision and reliability in achieving targeted vessel occlusion, particularly in small to medium-sized vessels, making them a standard choice in vascular interventions. Additionally, their extensive availability and established safety profile contribute to their dominance. This is due to the increasing demand for minimally invasive treatment options for cancer and other diseases.
However, the non-coil segment is emerging as the fastest-growing, driven with the aid of its expanding software in complicated instances like interventional oncology and trauma-related bleeding. Non-coil devices, together with microspheres, liquid embolics, and vascular plugs, offer greater versatility and higher outcomes for huge or irregularly formed vessels. Innovations inclusive of drug-eluting microspheres and biocompatible liquid agents have in addition fueled their demand by means of improving procedural precision and reducing recuperation instances. While the coil segment retains its leadership, the non-coil segment is poised to grow because of its capability to deal with evolving clinical desires, particularly in excessive demand for regions like oncology and personalized medicine.
Analysis by Application
Neurology is the dominating segment in the transcatheter embolization and occlusion devices market. The increasing incidence of fatal neurological disorders worldwide, such as cerebral palsy and cerebrovascular dysfunction, is expected to drive the growth of the field of neurology. According to the Society of Neurointerventional Surgery, there are currently over 140 Guglielmi detachable coils on the market which have been used to treat more than 125,000 patients worldwide. Neurological disorders, such as arteriovenous malformations (AVMs), brain aneurysms, and intracranial vascular diseases, require specialized treatment approaches. Transcatheter embolization and occlusion devices offer a less invasive alternative to traditional surgical procedures for the treatment of these conditions.
The oncology segment is expected to expand at the fastest CAGR by 2030 due to effective embolization method of treatment of liver and kidney cancer. Embolization has become an important method of treatment of various cancers such as liver, kidney, breast, pancreas, etc. This type of liver cancer or Hepatocellular carcinoma is usually treated with embolization. According to the National Center for Biotechnology Information, hepatocellular carcinoma is the third leading cause of cancer death worldwide. The growing adoption of minimally invasive procedures and the rising preference for targeted therapies have further propelled the demand for transcatheter embolization and occlusion devices in oncology.
Global Transcatheter Embolization and Occlusion Devices By Type
To get detailed analysis on other segments, Request For Free Sample Report
Transcatheter Embolization and Occlusion Devices Market Regional Insights
As per transcatheter embolization and occlusion devices market outlook, North America led the market with 29.7% revenue share in 2022. Availability of advanced healthcare infrastructure, well-defined regulatory framework, and skilled healthcare professionals are the major drivers for TEO demand devices in this region. According to the Centers for Disease Control and Prevention (CDC), these devices are used in cases of migraine and muscle spasms; Each year, 454,000 people are diagnosed with atrial fibrillation. The market is characterized by a few major players, including Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC, who are continuously innovating and expanding their product offerings to meet the growing demand.
As per transcatheter embolization and occlusion devices market analysis, Asia-Pacific is expected to grow at the fastest CAGR of 8.1% during the forecast period. The rapidly growing industry in emerging economies such as India, China and Malaysia attract cancer patients from all over the world. The region is also the most densely populated and has a large elderly population. According to a WHO report, 414 million people in Asia-Pacific are over the age of 60.40% of the population of Hong Kong and Japan is predicted to be over the age of 65 by 2050. These people are more likely to develop CVD, for which transcatheter embolization is a treatment which is not very difficult.
Global Transcatheter Embolization and Occlusion Devices By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Transcatheter Embolization and Occlusion Devices Market Dynamics
Transcatheter Embolization and Occlusion Devices Market Drivers
Increasing Incidence of Chronic Diseases and Cancer
- The increasing burden of chronic diseases such as cancer, liver disease and cardiovascular diseases is driving demand for less invasive medical solutions such as transcatheter embolization occlusion (TEO) devices. It is one of the leading causes of cancer death worldwide, especially for refractory tumors. Embolization techniques are emerging as an effective palliative treatment. This has led to the adoption of TEO devices by healthcare facilities to improve patient outcomes, contributing significantly to the transcatheter embolization and occlusion devices market growth.
Technological Advances in Embolization Devices
- The introduction of cutting-edge technologies such as drug solution microspheres, radioembolization, and biocompatible embolic agents is reshaping the market for TEO devices. These innovations increase the safety, accuracy and efficacy of the treatment, reducing patient recovery time. Such technological advances are expanding the role of TEO, increasing acceptance by health care providers, and driving growth in this field.
Transcatheter Embolization and Occlusion Devices Market Restraints
High Cost of Manufacturing and Equipment
- The cost of hemodialysis techniques and associated equipment remains a major barrier to widespread adoption, especially in developing regions. Advanced devices such as drug-elution beads and radio-embolization kits are often expensive, making them inaccessible to small healthcare facilities and low-income patients. This price sensitivity restricts market penetration in emerging economies.
Less Skilled Workers
- Successful use of TEO devices requires a high level of expertise, which is generally not available in many healthcare settings. Lack of trained radiologists and manpower is a major challenge for market expansion. Furthermore, the complexity of implants further limits their uptake in rural and underserved areas, limiting the overall potential for improvement.
Request Free Customization of this report to help us to meet your business objectives.
Transcatheter Embolization and Occlusion Devices Market Competitive Landscape
The competitive landscape of the transcatheter embolization and occlusion devices industry is characterized by numerous global and regional players investing in new products, strategies and geographical expansion to force them to build their market position strength. Key players focus on developing advanced embolic drugs, improving application, expanding their product lines to address various medical conditions. For example, partnerships between device manufacturing and clinical or research between institutions to stimulate clinical certification, product development and approval processes are common.
Top Player’s Company Profiles
- Boston Scientific Corporation (US)
- Terumo Corporation (Japan)
- Medtronic (Ireland)
- Abbott (US)
- Cook Medical Inc. (US)
- Penumbra, Inc. (US)
- Cerenovus (a subsidiary of Johnson & Johnson) (US)
- Guerbet S.A. (France)
- Merit Medical Systems, Inc. (US)
- AngioDynamics, Inc. (US)
- B. Braun Melsungen AG (Germany)
- Humares (Germany)
- Inari Medical, Inc. (US)
- MicroVention, Inc. (US)
- Endospan Ltd. (Israel)
- Teleflex Incorporated (US)
- Kaneka Corporation (Japan)
- Abbott Vascular (a division of Abbott Laboratories) (US)
- SentreHEART, Inc. (US)
- Vascular Technologies (US)
Recent Developments
- In January 2024, Boston Scientific announced the acquisition of Axonix, Inc., with the goal of expanding the urology division through differentiated technologies This acquisition is planned to enhance its market offerings has increased the availability of urinary and intestinal therapy devices.
- In April 2022, Boston Scientific Corporation announced that it had received FDA 510(k) approval for its innovative 'Embold' Fibered Detachable Coil. This medical device is specifically designated to cut off blood flow to the peripheral arteries.
- In July 2021, Terumo Corporation announced the launch of its innovative AZUR Vascular Plug. This innovation is fully microcatheter compatible, allowing closure of vessels up to 8mm in diameter. As part of the company’s strong embolization portfolio, the AZUR vascular plug system is designed to be used to reduce or prevent blood flow in vascular pathways of peripheral vascular perfusion.
Transcatheter Embolization and Occlusion Devices Key Market Trends
- Increasing Preference for Nonsurgical Treatment: Patients and health care providers are increasingly preferring minimally invasive surgery over conventional surgery due to decreased complications, shorter recovery times, and lower risks. Changing preferences has led to a demand for implantable devices as an alternative to open surgery. The trend is consistent with the global focus on patient-centered care, further increasing the use of TEO devices.
- Expansion of Applications Beyond Oncology: While embolization has been widely used in the treatment of cancer, its use has expanded to address other conditions such as uterine fibroids, varicoceles, gastrointestinal bleeding. TEO devices are used for a wide range of diseases and increase their interest in many aspects of treatment. New technologies are being developed that offer improved safety and efficacy, and these new technologies are expected to drive market growth in the coming years.
Transcatheter Embolization and Occlusion Devices Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the transcatheter embolization and occlusion devices market is poised for significant growth, driven by rising incidence of chronic diseases and advancements in device technology. However, challenges such as high costs and lack of skilled labor can hinder progress. Key trends including the preference for less invasive treatments and the expanded use of TEO devices are reshaping the market landscape as health systems prioritize and develop innovative patient-friendly solutions. The transcatheter embolization and occlusion devices market innovatively offers tremendous growth and offers huge possibilities.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 4.5 billion |
| Market size value in 2031 | USD 8.41 billion |
| Growth Rate | 7.20% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Transcatheter Embolization and Occlusion Devices Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Transcatheter Embolization and Occlusion Devices Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Transcatheter Embolization and Occlusion Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Transcatheter Embolization and Occlusion Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Transcatheter Embolization and Occlusion Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Transcatheter Embolization and Occlusion Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Transcatheter Embolization and Occlusion Devices Market Report Snapshots
- Transcatheter Embolization and Occlusion Devices Companies
- Transcatheter Embolization and Occlusion Devices Market Size
- Transcatheter Embolization and Occlusion Devices Market Analysis
- Transcatheter Embolization and Occlusion Devices Geographic Analysis
- Transcatheter Embolization and Occlusion Devices Market News
USA (+1) 351-333-4748
